Cancer clinical trials in the region Occitanie
174 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lung cancer
#NCT05118789
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
Targeted therapy
1
2
3 or more
Systemic Treatment-Naive
7 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse)
Nuvalent Inc.
Phase 2
Lung cancer
#NCT05118789
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
None
1
Targeted therapy
7 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse)
Nuvalent Inc.
Phase 2
Kidney cancer
#NCT05096390
Other
Locally Advanced
Metastatic
Systemic Treatment-Naive
Systemic Treatment-Naive
None
6 main criterias to confirm
IUCT Oncopôle (Toulouse)
Centre Léon Bérard
Phase 2
Pancreas cancer
#NCT05065801
Adenocarcinoma
Metastatic
Systemic Treatment-Naive
None
Surgery
Chemotherapy
Radiotherapy
Radiochemotherapy
6 main criterias to confirm
Centre Hospitalier de Perpignan (Perpignan), Institut du cancer de Montpellier (Montpellier), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
Liver and bile duct cancer
#NCT05063565
Hepatocellular carcinoma
Localized
Systemic Treatment-Naive
None
Unhealthy
A
Immunotherapy
Radiotherapy
8 main criterias to confirm
Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier)
Boston Scientific Corporation
Phase 2
Breast cancer
#NCT04985266
HER2 Negative
HR Positive
Localized
Surgery
Chemotherapy
Hormone therapy
None
Targeted therapy
7 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut Sainte Catherine (Avignon)
Fiducie de la Fondation Royal Marsden NHS
Phase 2
Lung cancer
#NCT04956640
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
Systemic Treatment-Naive
5 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Eli Lilly et compagnie
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT04954820
Neuroendocrine tumor
1
Systemic Treatment-Naive
Systemic Treatment-Naive
5 main criterias to confirm
IUCT Oncopôle (Toulouse), Institut du cancer de Montpellier (Montpellier)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
Colon cancer
Rectal cancer
#NCT04730544
Locally Advanced
Metastatic
MSI/dMMR
None
1
MSS
Immunotherapy
Bispecific T-cell engager antibodies
Immunotherapy
Bispecific T-cell engager antibodies
7 main criterias to confirm
Centre Hospitalier Universitaire de Toulouse (Toulouse), Institut du cancer de Montpellier (Montpellier), Institut Sainte Catherine (Avignon)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2
Liver and bile duct cancer
#NCT04727307
Hepatocellular carcinoma
Localized
Systemic Treatment-Naive
None
Unhealthy
A
Surgery
Transplant
8 main criterias to confirm
Centre Hospitalier de Perpignan (Perpignan), Centre Hospitalier Universitaire de Montpellier - Site Arnaud de Villeneuve (Montpellier), Centre Hospitalier Universitaire de Nîmes (Nîmes)
CHU de Montpellier